/u/WalkingHorse's posts in /r/LungCancerSupport

Year:

Only show posts with narrations

Unique immune cell linked to better lung cancer survival

1 upvotes

Mark as read: Add to a list

Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)

1 upvotes

Mark as read: Add to a list

Current status and factors influencing the work readiness of middle-aged and young postoperative lung cancer patients

1 upvotes

Mark as read: Add to a list

EGFR-Mutated NSCLC: Tepotinib/Osimertinib in Patients With MET Amplification

1 upvotes

Mark as read: Add to a list

CT-guided needle biopsy is not associated with increased ipsilateral pleural metastasis

1 upvotes

Mark as read: Add to a list

Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance

1 upvotes

Mark as read: Add to a list

Liquid biopsy and 18F-FDG PET/CT derived parameters as predictive factors of osimertinib treatment in advanced EGFR-mutated NSCLC

1 upvotes

Mark as read: Add to a list

LISTEN>>> Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer - Lung Cancer Update Podcast

1 upvotes

Mark as read: Add to a list

PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations

1 upvotes

Mark as read: Add to a list

Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics | European Journal of Medical Research

1 upvotes

Mark as read: Add to a list

Title	Upvotes	Mark as read	Favorited	Rating	Add to a list
Unique immune cell linked to better lung cancer survival	1
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)	1
Current status and factors influencing the work readiness of middle-aged and young postoperative lung cancer patients	1
EGFR-Mutated NSCLC: Tepotinib/Osimertinib in Patients With MET Amplification	1
CT-guided needle biopsy is not associated with increased ipsilateral pleural metastasis	1
Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance	1
Liquid biopsy and 18F-FDG PET/CT derived parameters as predictive factors of osimertinib treatment in advanced EGFR-mutated NSCLC	1
LISTEN>>> Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer - Lung Cancer Update Podcast	1
PD-L1 Expression Remains Primary Guide for NSCLC Treatment Selection in the Absence of Targetable Mutations	1
Evaluation of the prognosis in patients with small-cell lung cancer treated by chemotherapy using tumor shrinkage rate-based radiomics \| European Journal of Medical Research	1